Jubilant Pharmova Q4 Results
- BSE: 530019
- NSE: JUBLPHARMA
- ISIN: INE700A01033
- Sector: Biotechnology & Drugs
BSE
986.30
5.80 (0.59%)
5.80 (0.59%)Volume11.15 K
Updated: Tue 6 Oct, 2026 | 15:29:27
NSE
9853.40 (0.35%)
3.40 (0.35%)Volume1.75 L
Updated: Tue 6 Oct, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Jubilant Pharmova Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2,081.20 | 1,993.40 | 4.40% | 1,757.10 | 23.74% |
| Depreciation/ Amortization | 116.80 | 120.70 | -3.23% | 101.00 | 22.69% |
| Operating Income | 208.80 | 129.10 | 61.74% | 1.50 | -15.43% |
| Net Income | 119.40 | 55.90 | 113.60% | -58.60 | -22.27% |
| Other Operating Expenses Total | 470.50 | 410.30 | 14.67% | 404.80 | 28.31% |
| Net Income Before Taxes | 176.00 | 93.40 | 88.44% | -53.70 | -14.56% |
| Total Revenue | 2,290.00 | 2,122.50 | 7.89% | 1,758.60 | 18.73% |
| Selling/ General/ Admin Expenses Total | 766.90 | 706.40 | 8.56% | 555.00 | 29.85% |
| Diluted Normalized EPS | 8.11 | 5.01 | 61.68% | 3.25 | -17.45% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.